Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...
Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...
BabyCenter on MSN5d
Should babies, toddlers, and older children get the COVID-19 vaccine?With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
It is also FDA-authorised under an EUA as a third primary series dose in individuals 12 years old and above who have certain kinds of immunocompromises. The Pfizer/BioNTech bivalent COVID-19 ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Pfizer has now announced that it intends to sell Comirnaty for between $110 and $130 per dose – roughly four times the current price, and 100 times The People’s Vaccine Alliance’s estimated ...
Pfizer's shot is also approved as a two-dose series administered six months apart. With Blenrep's revival, GSK dials up long-term sales goal—again—despite RSV vaccine woes The ACIP has already ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback